Association Between Glycosylated Hemoglobin A1c and Bone Biochemical Markers in Type 2 Diabetic Postmenopausal Women: a Cross-sectional Study

Overview

Journal BMC Endocr Disord

Publisher Biomed Central

Specialty Endocrinology

Date 2019 Mar 15

PMID 30866902

Citations 15

Authors

Lianzi Wang

Tao Li

Jiaqing Liu

Xian Wu

Huihui Wang

Xuemei Li

Enjun Xu

Qiuli Chen

Chuan Yan

Huimin Li

Yuanhong Xu

Wei Wei

Affiliations

Soon will be listed here.

Abstract

Background: type 2 diabetes mellitus (T2DM) is a complicated disease that can affect bone health, but the change in bone biochemical markers caused by T2DM was controversial, so the aim of this study was to investigate whether there was a discrepancy in the levels of bone biochemical markers between postmenopausal women with T2DM and non-diabetic women and to explore the relationship between the level of glycosylated hemoglobin A1c (HbA1c) and bone biochemical markers in these subjects.

Methods: A total of 237 type 2 diabetic postmenopausal women visiting the First Affiliated Hospital of Anhui Medical University from January 2017 to October 2018 and 93 healthy postmenopausal women were retrospectively enrolled. The differences in the levels of bone biochemical markers between patients and controls were analyzed by one-way ANOVA or chi-square test. The relationship between HbA1c and bone biochemical markers was analyzed by multivariate regression, forest plot and fitted curve.

Results: Bone formation markers including N-MID osteocalcin and procollagen type 1 amino-terminal pro-peptide (PINP) were decreased in postmenopausal women with T2DM compared to controls (17.42 ± 9.50 vs 23.67 ± 7.58, p < 0.001; 48.47 ± 27.27 vs 65.86 ± 21.06, p < 0.001, respectively), but the bone resorption markers β-crossLaps (β-CTX) was no difference between the two groups (0.57 ± 0.28 vs 0.55 ± 0.21, p = 0.868). Multivariate regression showed that HbA1c was inversely associated with N-MID osteocalcin and PINP after adjusting for age, BMI, menopauses years, diabetic duration, TC, TG, HDL-c, LDL-c, creatinine, UA and eGFR. The adjusted coefficients for N-MID osteocalcin and PINP per 1% HbA1c decrease were - 0.71 (- 1.19, - 0.22) and - 1.79 (- 3.30, - 0.28), respectively. A segmentation effect was seen in the fitted curve between HbA1c and β-CTX with an inflection point at 7.4% of HbA1c, the highest quartile of β-CTX (> = 0.74 ng/ml) showed a significantly negative with HbA1c. No significant association was seen between HbA1c and other biochemical markers.

Conclusions: Our study found that bone formation was inhibited in postmenopausal women with T2DM, but bone resorption was not affected, and poor glycemic control was related to lower levels of bone formation, may increase the risk of bone fracture in postmenopausal women with T2DM.

Citing Articles

CTX-1 and TRACP-5b as biomarkers for osteoporosis risk in type 2 diabetes mellitus: a cross-sectional study.

Roy M, Majid H, Khan P, Sharma N, Kohli S, Islam S J Diabetes Metab Disord. 2024; 23(2):2055-2064.

PMID: 39610562 PMC: 11599675. DOI: 10.1007/s40200-024-01464-w.

Effect of type 2 diabetes on biochemical markers of bone metabolism: a meta-analysis.

Yang J, Zhang Y, Liu X, Chen B, Lei L Front Physiol. 2024; 15:1330171.

PMID: 39100278 PMC: 11294215. DOI: 10.3389/fphys.2024.1330171.

Association of a history of gestational diabetes mellitus with osteoporosis, bone mineral density, and trabecular bone score in postmenopausal women.

Lu B, Zhang L Diabetol Metab Syndr. 2023; 15(1):215.

PMID: 37884990 PMC: 10605046. DOI: 10.1186/s13098-023-01194-8.

Structural role of osteocalcin and its modification in bone fracture.

Bailey S, Poundarik A, Sroga G, Vashishth D Appl Phys Rev. 2023; 10(1):011410.

PMID: 36915902 PMC: 9999293. DOI: 10.1063/5.0102897.

Gut microbiome dysregulation drives bone damage in broiler tibial dyschondroplasia by disrupting glucose homeostasis.

Xu T, Chen P, Zhang C, Shaukat A, Lin L, Yue K NPJ Biofilms Microbiomes. 2023; 9(1):1.

PMID: 36596826 PMC: 9810666. DOI: 10.1038/s41522-022-00360-6.

References

Leidig-Bruckner G, Ziegler R . Diabetes mellitus a risk for osteoporosis?. Exp Clin Endocrinol Diabetes. 2001; 109 Suppl 2:S493-514. DOI: 10.1055/s-2001-18605. View

Okuno S, Inaba M, Kitatani K, Ishimura E, Yamakawa T, Nishizawa Y . Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients. Osteoporos Int. 2004; 16(5):501-9. DOI: 10.1007/s00198-004-1712-4. View

Achemlal L, Tellal S, Rkiouak F, Nouijai A, Bezza A, Derouiche E . Bone metabolism in male patients with type 2 diabetes. Clin Rheumatol. 2005; 24(5):493-6. DOI: 10.1007/s10067-004-1070-9. View

Botolin S, McCabe L . Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem. 2006; 99(2):411-24. DOI: 10.1002/jcb.20842. View

Dobnig H, Piswanger-Solkner J, Roth M, Obermayer-Pietsch B, Tiran A, Strele A . Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab. 2006; 91(9):3355-63. DOI: 10.1210/jc.2006-0460. View

Oz S, Guven G, Kilicarslan A, Calik N, Beyazit Y, Sozen T . Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc. 2006; 98(10):1598-604. PMC: 2569751. View

Lee N, Sowa H, Hinoi E, Ferron M, Ahn J, Confavreux C . Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130(3):456-69. PMC: 2013746. DOI: 10.1016/j.cell.2007.05.047. View

Hamada Y, Fujii H, Fukagawa M . Role of oxidative stress in diabetic bone disorder. Bone. 2009; 45 Suppl 1:S35-8. DOI: 10.1016/j.bone.2009.02.004. View

Hamilton E, Rakic V, Davis W, Chubb S, Kamber N, Prince R . A five-year prospective study of bone mineral density in men and women with diabetes: the Fremantle Diabetes Study. Acta Diabetol. 2011; 49(2):153-8. DOI: 10.1007/s00592-011-0324-7. View

10.

Zakeri Z, Azizi Z, Mehrabifar H, Hashemi M . Evaluation of bone mineral density in premenopausal women with type-2 diabetes mellitus in Zahedan, southeast Iran. J Pak Med Assoc. 2011; 61(5):443-5. View

11.

Schwartz A, Margolis K, Sellmeyer D, Vittinghoff E, Ambrosius W, Bonds D . Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial. Diabetes Care. 2012; 35(7):1525-31. PMC: 3379596. DOI: 10.2337/dc11-2184. View

12.

Puar T, Khoo J, Cho L, Xu Y, Chen Y, Chuo A . Association between glycemic control and hip fracture. J Am Geriatr Soc. 2012; 60(8):1493-7. DOI: 10.1111/j.1532-5415.2012.04052.x. View

13.

Xuan Y, Sun L, Liu D, Zhao L, Tao B, Wang W . Positive association between serum levels of bone resorption marker CTX and HbA1c in women with normal glucose tolerance. J Clin Endocrinol Metab. 2014; 100(1):274-81. DOI: 10.1210/jc.2014-2583. View

14.

Terzi R, Dindar S, Terzi H, Demirtas O . Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia. Metab Syndr Relat Disord. 2014; 13(2):78-83. DOI: 10.1089/met.2014.0074. View

15.

Starup-Linde J, Vestergaard P . Biochemical bone turnover markers in diabetes mellitus - A systematic review. Bone. 2015; 82:69-78. DOI: 10.1016/j.bone.2015.02.019. View

16.

Okada Y, Okada M . Effects of methanolic extracts from edible plants on endogenous secretory receptor for advanced glycation end products induced by the high glucose incubation in human endothelial cells. J Pharm Bioallied Sci. 2015; 7(2):145-50. PMC: 4399013. DOI: 10.4103/0975-7406.148783. View

17.

Razi F, Esmaili M, Nasli Esfahani E, Yaghmaei P, Qorbani M, Mohammadi Z . Bone structure and turnover in postmenopausal women with type 2 diabetes mellitus. Menopause. 2015; 23(3):280-5. DOI: 10.1097/GME.0000000000000524. View

18.

Ogata M, Ide R, Takizawa M, Tanaka M, Tetsuo T, Sato A . Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes. Nutrition. 2015; 31(11-12):1394-401. DOI: 10.1016/j.nut.2015.06.012. View

19.

Starup-Linde J, Lykkeboe S, Gregersen S, Hauge E, Langdahl B, Handberg A . Differences in biochemical bone markers by diabetes type and the impact of glucose. Bone. 2015; 83:149-155. DOI: 10.1016/j.bone.2015.11.004. View

20.

Furst J, Bandeira L, Fan W, Agarwal S, Nishiyama K, McMahon D . Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes. J Clin Endocrinol Metab. 2016; 101(6):2502-10. PMC: 4891790. DOI: 10.1210/jc.2016-1437. View